This inventor holds 2 USPTO granted patents. Top assignees: Edna Mcconnell Clark Foundation, Johns Hopkins University. Active years: 1980-1982.
Company Filing History:
Years Active: 1980-1982
Title: The Innovations of Ernest Bueding
Introduction
Ernest Bueding is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of pharmaceuticals, particularly in methods that enhance drug safety and efficacy. With a total of 2 patents, Bueding's work has had a lasting impact on medical science.
Latest Patents
Bueding's latest patents include a method for reducing or avoiding the mutagenic activity of drugs. This innovative method involves administering an antibacterial agent alongside the drug to prevent its transformation into a mutagenic metabolite in the host. Another significant patent is for the compound 2-Chloro-4-(4-lower alkyl-1-piperazinyl)benzenemethanol, N.sup..omega. -oxides and their acid addition salts. This compound is prepared by oxidizing the corresponding benzenemethanol and includes pharmaceutical compositions for treating schistosomiasis.
Career Highlights
Throughout his career, Bueding has worked with prestigious organizations such as Johns Hopkins University and the Edna McConnell Clark Foundation. His research has focused on improving drug formulations and their applications in treating various diseases.
Collaborations
Bueding has collaborated with notable colleagues, including Leslie M. Werbel and Donald F. Worth. Their combined expertise has contributed to advancements in pharmaceutical research and development.
Conclusion
Ernest Bueding's innovative work in pharmaceuticals has led to important advancements in drug safety and treatment methods. His contributions continue to influence the field and improve patient outcomes.